Printer Friendly
The Free Library
4,546,951 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

New drug for ADHD.


A new type of medication, sold as Strattera, has been launched for children suffering from Attention Deficit Hyperactivity Disorders. Strattera is unlike other medicines in that it contains no amphetamine
1. a sympathomimetic amine with a stimulating effect on both the central and peripheral nervous systems, used in the treatment of narcolepsy and attention-deficit, usually as the sulfate or aspartate salt. Abuse may lead to dependence.
2. any drug closely related to amphetamine and having similar actions, e.g., methamphetamine.
 or methylphenidate methylphenidate /meth·yl·phen·i·date/ (meth?il-fen´i-dat) a central stimulant
1. producing stimulation.
2. an agent which stimulates.

central stimulant  a stimulant of the central nervous system.
diffusible stimulant  one that acts quickly and strongly, but transiently.
, used in the form of the hydrochloride salt in the treatment of attention-deficit in children and narcolepsy.

meth·yl·phen·i·date (m
, which are both stimulants. Dr Michael McDowell, a Brisbane-based developmental paediatriclan who conducted clinical trials for the new medicine, said that excluding stimulants had eliminated the possibility of addiction.

The two types of ADHD medication currently available work by stimulating a particular brain chemical, dopamine, which controls a number of brain functions and relays messages. Strattera targets a different brain chemical, noradrenaline noradrenaline /nor·adren·a·line/ (nor?ah-dren´ah-lin) norepinephrine., which affects impulsivity and control. The drug is administered only once a day, but it can cost over $90 a month and is not listed on the Pharmaceutical Benefits Scheme.

A study published in The Medical Journal of Australia in 2002 showed that Australia was the world's third-highest prescriber of ADHD medication and there were some concerns that the drugs were given unnecessarily (Canberra Times, 15/4/04, p.10; Sydney Morning Herald, 15/4/04, p.3; West Australian, 16/4/04, p.3).
COPYRIGHT 2004 Australian Clearing House for Youth Studies
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Health & safety; Strattera
Author:Colman, Adrian
Publication:Youth Studies Australia
Article Type:Brief Article
Geographic Code:8AUST
Date:Jun 1, 2004
Words:179
Previous Article:'Kiddie speed'.(Health & safety)(prescriptions of dexamphetamine for children)(Brief Article)
Next Article:Obesity and diabetes.(Health & safety)(Brief Article)
Topics:



Related Articles
Teens' ADHD treatment gets low-dose boost.(attention-deficit hyperactivity disorder)(Brief Article)
Taking a Look at Kids and Legal Drugs. (On First Reading).(Brief Article)
Medication interventions for ADHD youth: a primer for school and mental health counselors.(Counseling Adolescents)
Med use widens in kids with ADHD. (Behavior).(attention-deficit hyperactivity disorder)(Brief Article)
Attention-deficit/hyperactivity disorder: an update. (Review Article).
When children with attention-deficit/hyperactivity disorder become adults. (Featured CME Topic: Pediatrics).
ADHD & Women's health.(attention-deficit hyperactivity disorder)
ADHD drugs. (Drugs).(attention deficit hyperactivity disorder)(drug abuse risk among hyperactive children)(Brief Article)
A three-year study into the ADHD treatment drug atomoxetine is to be conducted by researchers at the Children's Hospital at Westmead's Adolescent...

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles